TrialScientific reports2017

Six-month efficacy of platelet-rich plasma for carpal tunnel syndrome: A prospective randomized, single-blind controlled trial.

Yung-Tsan Wu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.